| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Chemistry, University of Toledo, 2801 W. Bancroft Street, Toledo, OH 43606, USA
2 Department of Microbiology and Molecular Genetics, Michigan State University, 2215 Biomedical Physical Sciences, East Lansing, MI 48824, USA
3 Department of Microbiology, The University of Chicago, 920 E. 58th Street, Chicago, IL 60637, USA
Correspondence
Robert R. Brubaker
t-rbruba{at}bsd.uchicago.edu
 |
ABSTRACT |
|---|
 TOP ABSTRACT INTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
T·A) causing replacement of leucine (encoded by UUG) for valine (encoded by GUG) at amino acid position 363. The gene from Y. pestis KIM possesses a unique second transversion (G·CT·A) at amino acid 146 causing substitution of aspartic acid (encoded by GAU) with tyrosine (encoded by UAU). We show in this study that Y. pestis expresses aspA as cross-reacting immunological material (CRIM). Functional and inactive aspA of Y. pseudotuberculosis PB1 and Y. pestis KIM, respectively, were then cloned and expressed in AspA-deficient Escherichia coli. After purification to near homogeneity, the products were subjected to biochemical analysis and found to exhibit similar secondary, tertiary and quaternary (tetrameric) structures as well as comparable Michaelis constants for L-aspartic acid. However, the kcat of the Y. pestis CRIM of strain KIM is only about 0.1 % of that determined for the active AspA of Y. pseudotuberculosis. Return of valine for leucine at position 363 of the Y. pestis enzyme restored normal turnover (kcat 86±2 s–1) provided that the amino acid substitution at position 146 was also reversed. These observations have important implications for understanding the nature of the stringent low-calcium response of Y. pestis and its role in promoting acute disease.
|
INTRODUCTION |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
), implying that high lethality reflects only a few genetic changes. Comparison of the annotated genomes of Y. pestis (Chain et al., 2006; Deng et al., 2002; Parkhill et al., 2001; Zhou et al., 2004) and Y. pseudotuberculosis (Chain et al., 2004) verified and extended earlier studies showing that cells of Y. pestis have both gained new functions and lost important features of Y. pseudotuberculosis (Brubaker, 1991; Perry & Fetherston, 1997). Salient new genes were acquired by lateral transfer of two unique plasmids (Ferber & Brubaker, 1981). These are the 
10 kb pPCP encoding a plasminogen activator accounting for the low subcutaneous LD50 (<10 cells) of Y. pestis in mice (Brubaker et al., 1965; Sodeinde et al., 1992) and the 100 kb pMT, which carries structural genes for capsular antigen fraction 1 and murine toxin (Kutyrev et al., 1986). Loss mutations include conversion of yadA and ylpA encoded by the shared 70 kb low-calcium response (LCR) plasmid (termed pCD in Y. pestis and pYV in Y. pseudotuberculosis) into pseudogenes in Y. pestis (Hu et al., 1998; Rosqvist et al., 1988). The LCR phenotype of Y. pestis is more stringent than that of Y. pseudotuberculosis (Brubaker, 2007) and is defined as the ability to either promote abrupt bacteriostasis in Ca2+-deficient medium at 37 °C accompanied by upregulation of a pCD/pYV-encoded type 3 secretion system (T3SS) or maintain vegetative growth with added Ca2+ while downregulating the T3SS (Lct+) (Brubaker, 2007). The chromosome of Y. pestis contains large inversions, transpositions, and numerous small deletions and additions relative to its Y. pseudotuberculosis progenitor. These changes, as well as acquisition by Y. pestis of over 70 IS insertions (Chain et al., 2006; Deng et al., 2002; Parkhill et al., 2001; Zhou et al., 2004), have resulted in loss of about 13 % of all functional genes of Y. pseudotuberculosis (Chain et al., 2004). A few of these mutations, especially those associated with downregulation of inflammation, are almost certainly associated with acute disease (Kawahara et al., 2002; Kukkonen et al., 2004). The remaining missing genes are largely regulatory in nature or encode metabolic functions; their elimination accounts for the established nutritional requirements of Y. pestis (Chain et al., 2004).
Chromosomal annotation did not provide obvious explanations for the loss in Y. pestis of detectable glucose-6-phosphate dehydrogenase (Zwf) (Mortlock, 1962; Mortlock & Brubaker, 1962) and aspartate ammonia-lyase or aspartase (AspA) (Brubaker, 2005, 2007; Dreyfus & Brubaker, 1978). Zwf is required for synthesis of pentose from hexose and its absence may account for a temperature-dependent toxic effect of glucose on Lcr+ Y. pestis (Brownlow & Wessman, 1960). AspA activity catalyses the deamination of L-aspartate to form fumarate, a component of the tricarboxylic acid (TCA) cycle; thus its absence prevents catabolism of L-aspartate (and metabolically related amino acids) via this efficient bioenergetic mechanism. Indeed, the LCR of Y. pestis is accompanied by excretion of L-aspartic acid at the expense of exogenous L-glutamate, causing a loss of metabolic carbon that otherwise would be conserved as oxaloacetate (Brubaker, 2005, 2007). Regeneration of lost oxaloacetate via phosphoenolpyruvate carboxykinase and phosphoenolpyruvate carboxylase (Baugh et al., 1964) accounts for the stimulatory effect of CO2 on growth of Y. pestis (Delwiche et al., 1959; Surgalla et al., 1964).
Further comparison of zwf and aspA of Y. pseudotuberculosis and Y. pestis revealed putative missense mutations in the latter (Chain et al., 2004). For example, proline replaces serine at amino acid position 158 in the inactive Zwf of Y. pestis; this change is caused by a single base transition (T·AC·G). Similarly, a single base transversion (G·CT·A) at amino acid position 363 of AspA causes exchange of valine in the active enzyme of Y. pseudotuberculosis for leucine in Y. pestis (Chain et al., 2004, 2006; Deng et al., 2002; Parkhill et al., 2001; Zhou et al., 2004). While no other substitutions occur in Zwf, Y. pestis strain KIM (used in this study) also possesses a unique second base transversion (G·CT·A) at position 146 of AspA, causing replacement of aspartate by tyrosine (Deng et al., 2002) (Fig. 1). The substitution at position 146 was not reported for other yersiniae, including strains of Y. pseudotuberculosis.
|
). This heat-shock protein is also essential for the biological activity of citrate synthase (Grallert et al., 1998); thus T3SS-dependent depletion of GroEL could cause accumulation of oxaloacetate and its subsequent transamination and excretion as L-aspartate. Other obvious alternatives exist, although a block in transcription of aspA seems unlikely as judged by its evident normal expression as determined by microarray analysis (Motin et al., 2004). The aims of this study were to demonstrate that AspA is expressed as cross-reacting immunological material (CRIM) in Y. pestis and to determine if the conserved single G·CT·A transversion at amino acid position 363 of AspA accounts for loss of enzymic activity. |
METHODS |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
) of serogroup 1b (Thal & Knapp, 1971) and Y. pestis KIM (Finegold et al., 1968) of the Medievalis biovar (Devignat, 1951). Avirulent Lcr– mutants of both species were selected on magnesium oxalate agar (Higuchi & Smith, 1961) and a mutant of Y. pestis KIM lacking the 100 kb pigmentation sequence was isolated on Congo red agar (Surgalla & Beesley, 1969). Transformed cells of Escherichia coli JRG1476 (aspA) were used to prepare the aspA products of Y. pestis and Y. pseudotuberculosis. The chemically defined medium employed previously for microarray analysis (Motin et al., 2004) and definition of the LCR (Brubaker, 2005; Fowler & Brubaker, 1994) was used to cultivate yersiniae for enzyme analysis. Conditions of growth, modifications of the medium that induce bacteriostasis versus steady-state growth, and preparation of the variations used in this study have been described in detail (Brubaker, 2007). The medium used in these experiments contained L-glutamate (25 mM) and Na+ (100 mM) in the presence (4.0 mM) and absence of added Ca2+. E. coli JRG1476 was grown in Luria broth with kanamycin (100 µg ml–1) for preparation of cloned aspA products as defined below.
Enzyme analysis.
Lcr+ and Lcr– yersiniae were cultivated in chemically defined medium (Brubaker, 2007), harvested by centrifugation at 4 °C (10 000 g for 30 min), suspended and washed twice by similar centrifugation in cold 0.033 M potassium phosphate buffer, pH 7.0, brought to an OD620 of 400 in 0.05 M Tris/HCl buffer, pH 7.8, and disrupted by passage through a French pressure cell. The resulting preparation was again centrifuged as described and the cell-free extract carefully removed with a pipette, passed through a 0.22 µm low-protein-binding filter (Millipore), and dialysed overnight against 0.01 M Tris/HCl buffer, pH 7.8, containing DTT (1.0 mM). The resulting cell-free extracts were used immediately for enzymic analysis. In all cases, protein concentration was determined by the Lowry method.
AspA activity in these preparations was estimated by determining the L-aspartic acid-dependent release of 
with Nessler's reagent as undertaken previously (Dreyfus & Brubaker, 1978). The reaction mixture consisted of 250 µmol Tris/HCl buffer (pH 7.0), 5.0 µmol MgCl2, and dialysed cell-free extract in a total volume of 4.5 ml. The assay was started by addition of 250 µmol sodium L-aspartate in a volume of 0.5 ml, and samples of 0.5 ml were removed at intervals and added to Eppendorf tubes containing 0.1 ml 1.5 M trichloroacetic acid. The tubes were then centrifuged at highest speed for 1 min in a Beckman II microfuge and 0.5 ml clear supernatant fluid was carefully removed and added to a tube containing 8.5 ml distilled water. These samples received 1.0 ml Nessler's reagent and, after incubation for 10 min, were assayed for asparaginase activity by measuring A480 (Yellin & Wriston, 1966). The resulting values were then evaluated against a standard curve, prepared immediately before each determination by assays using known concentrations of NH4Cl in samples of 10 ml containing the same concentrations of trichloroacetic acid and Nessler's reagent that were used to prepare samples for spectrophotometric analysis. AspA activity in purified preparations was measured by monitoring the appearance of fumarate at 240 nm (
=2.53 mM–1 cm–1) (Karsten et al., 1985) in an assay buffer consisting of HEPES, pH 8.0 (50 mM), magnesium acetate (10 mM) and L-aspartate (20 mM). Enzyme units were defined as µmol product generated per minute. The kinetic parameters of the yersiniae aspartases were measured by varying the concentration of L-aspartate and fitting the data to the Michaelis–Menten equation. Kinetic assays were performed on either a Perkin-Elmer Lambda-1 or a Cary 50 UV/visible spectrophotometer at a constant temperature of 20 °C. Citrate synthase in crude extracts was measured by determining the oxaloacetate-dependent release of CoA from acetyl-CoA at 412 nm (Srere, 1969). L-Glutmate : oxaloacetate transaminase and L-glutamate dehydrogenase in these samples were determined as described previously (Dreyfus & Brubaker, 1978).
Cloning, expression and purification of AspA.
The aspA genes of yersiniae were PCR-amplified using the conserved primers CGA214 (5'-GAAGGTTCATATGTCAAATAACATTCG-3') and CGA215 (5'-CCGAGAAAATGAACAATAAGCTTAATATTC-3'). CGA214 incorporates a NdeI site at the start codon and CGA215 incorporates a HindIII site at the stop codon of aspA (underlined) These enzymes were used to digest the products, which were ligated into the expression vector pET24a digested with the same enzymes. The resulting plasmids were transformed into the aspA-deficient E. coli JRG1476 (Guest et al., 1984). Mutagenic primers were obtained from Integrated DNA Technologies. AspA production was initiated during cultivation at 37 °C in a shaker bath by addition of 1 mM IPTG, followed by incubation for an additional 5 h at 32 °C. Approximately 2.5 g of wet cell paste was harvested from each litre of growth medium. This material was then suspended in the purification buffer (50 mM potassium phosphate, pH 6.5, with 1 mM EDTA and 1 mM DTT) and the organisms were disrupted by sonication. Soluble proteins were fractionated in purification buffer with a 0 to 1.0 M sodium chloride gradient on successive anion-exchange Sepharose XL high-capacity and Source 30Q high-resolution chromatography columns (Amersham Bioscience). The same purification protocol was used for preparation of the cloned aspA products of both yersiniae. The overall yield of highly purified (>95 %) enzyme was about 50 mg protein from each litre of growth medium.
Analysis for cross-reacting immunological material (CRIM).
Biologically active AspA from E. coli K-12 and Y. pseudotuberculosis PB1 and the inactive protein from Y. pestis were isolated essentially as outlined above and used to prepare polyclonal antiserum in rabbits. This process entailed use of the immunization regimen used previously for LcrV (Une & Brubaker, 1984) except that adjuvant was omitted; generation of precipitating antibodies was verified by diffusion in agar against the purified proteins. Immunoblots were undertaken as described previously (Motin et al., 1994).
Site-directed mutagenesis.
Mutations of aspA from Y. pseudotuberculosis and Y. pestis were constructed using the Quik-Change II Site Directed Mutagenesis kit (Stratagene) and confirmed by DNA sequencing (MWG). A single base change is needed to alter the GUG codon (valine) to UUG (leucine) in order to obtain the V363L Y. pseudotuberculosis mutant. The Y. pestis L363V mutation also requires only this single base change and, in order to make the Y146D mutant of Y. pestis KIM, the UAU codon of tyrosine was changed to the GAU codon of aspartate. The Y146D/L363V Y. pestis double mutant incorporated both of these base changes. These mutants were expressed and purified by using the same protocol as described above for the native enzymes.
Quaternary structure determination.
The purified yersiniae aspartases (0.5–1.0 mg ml–1 in the phosphate purification buffer) were studied by dynamic light scattering (DLS) (DynaPro Titan, Wyatt Technologies) at 20 °C and 4 °C to determine the average particle size in solution. Native gel electrophoresis was carried out in Tris/glycine buffer (25 mM Tris, pH 8, 200 mM glycine) using 4–12 % Bistris polyacrylamide gels (Invitrogen). Gel filtration studies were conducted on a Superdex 200 column in 50 mM potassium phosphate, pH 6.5, with 1 mM EDTA and 1 mM DTT.
Circular dichroism (CD) spectroscopy.
To compare the tertiary structure of Y. pestis, Y. pseudotuberculosis and the mutant V363L aspartases, the purified enzymes were examined by CD spectroscopy (Cary 62DS spectrometer) over the range 190–260 nm at room temperature. The enzyme concentrations in these solutions were varied from 6 to 20 µM, and the spectra reported represent an average of five scans.
Mass spectrometry.
The purified aspartases from Y. pestis and Y. pseudotuberculosis were examined on a Q-TOF2 electrospray ionization mass spectrometer (ESI-MS) to determine accurate molecular masses. Each enzyme form was dialysed into 10 mM ammonium acetate buffer, pH 6.5, and about 0.5 mg of each protein was used for mass analysis.
|
RESULTS |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
). The latter, however, was evidently unable to regenerate oxaloacetate in Y. pestis by recycling into the TCA as judged by the observed loss of AspA activity. The presence of similar levels of citrate synthase activity in both yersiniae suggests that a limitation of this enzyme in Y. pestis does not promote accumulation of oxaloacetate and its attendant conversion to L-aspartate. Finally, no significant differences were detected between the yersiniae in the activity of (primarily anabolic) L-glutamate dehydrogenase. The specific activity of these enzymes was not significantly influenced by Ca2+. Considered together, these findings indicate that the reported secretion of L-aspartate during the LCR is consistent with the observed deficiency of AspA activity in Y. pestis.
|
); thus we considered the possibility that inactive AspA in this species reflects a lesion in translation. To examine this prospect, polyclonal rabbit antiserum was raised against highly purified AspA activity from Lcr– cells of Y. pseudotuberculosis. The resulting antiserum reacted in immunoblots with the homologous 50 kDa peptide of Y. pseudotuberculosis, the corresponding material purified from Y. pestis, and crude extracts of Y. pestis, Y. pseudotuberculosis and E. coli (Fig. 2). A slight excess of the antiserum also eliminated >99 % of the enzymic activity of AspA from Y. pseudotuberculosis. These findings indicate that Y. pestis normally expresses defective AspA as a CRIM and suggest that one or both of the known changes in primary structure of the inactive enzyme (Y146D and L363V) accounts for loss of enzymic activity.
|
), which is comparable to that of AspA from E. coli (Karsten et al., 1985). In contrast, the specific activity of the similarly prepared CRIM of Y. pestis was more than 300-fold lower (0.2 units mg–1). The catalytic rates of the Y. pestis and Y. pseudotuberculosis enzymes were measured at varying concentrations of L-aspartate to assess whether this reduction was a consequence of changes in substrate recognition. The Km for L-aspartate was comparable between these two enzyme forms, but the kcat of the Y. pestis CRIM was significantly reduced (Table 2). To establish the importance of position 363, a mutant of the Y. pseudotuberculosis AspA was constructed where valine was replaced by leucine to mimic the nearly inactive CRIM of Y. pestis. The latter was purified, kinetically characterized, and found to have a low specific activity of 0.2 units mg–1 similar to that of the Y. pestis AspA. Accordingly, the single conservative replacement of one aliphatic amino acid by another at position 363 was sufficient to dramatically attenuate catalytic activity without inducing gross structural changes.
|
). As previously noted, the only other difference between the enzyme from Y. pseudotuberculosis PB1 and Y. pestis KIM is a non-conservative replacement in the latter of tyrosine for aspartic acid at position 146, although aspartic acid occupies this position in other yersiniae, including Y. pestis CO92 (Parkhill et al., 2001). A Y146D variant of the Y. pestis KIM AspA was prepared and characterized but this replacement similarly failed to enhance catalysis (Table 2). Since neither of these single reversions alone resulted in significant recovery of enzymic activity, either one or the other forward mutation is evidently sufficient to cause the observed inhibition. To verify this assumption, a double Y146D/L363V mutant possessing an amino acid sequence identical to that of the fully active Y. pseudotuberculosis enzyme was prepared and subjected to enzymic analysis. These two changes resulted in an enzyme form with high specific activity (72 units mg–1) and kinetic parameters that were indistinguishable from the native Y. pseudotuberculosis AspA (Table 2).
Structural comparison of AspA from Y. pseudotuberculosis and the Y. pestis CRIM
The similar Km for L-aspartic acid suggested that the primary structure responsible for substrate recognition and binding was not affected by the Y146D and L363V substitutions but that these mutations alter the positioning of catalytic residues at the active site, thereby causing a loss of activity. By analogy with the well-established tetrameric structure of E. coli AspA (Watanabe et al., 1981), the enzymes from yersiniae are also expected to exist as tetramers. However, because the active site of AspA is formed at the interface between subunits (Shi et al., 1997), any changes in subunit association as a consequence of these point mutations might alter the active site structure and therefore affect catalytic activity.
This possibility was investigated by analysis of the quaternary structure and subunit conformation of these enzyme forms. The average particle size of the AspA species was determined in solution at 20 °C and 4 °C by DLS. Both enzymes showed a similar peak via DLS at both temperatures, with a particle size predicting a molecular mass of 130±20 kDa. The actual molecular mass of the AspA subunit was 52 kDa, so the expected mass of the tetramer should be about 200 kDa. Mass prediction by DLS assumes that the protein has a spherical shape, whereas the structure of tetrameric E. coli AspA is quite elongated (Shi et al., 1997), so the value predicted by DLS deviates from the actual mass. To compensate for the errors in mass estimation due to this non-spherical shape, the well-characterized E. coli enzyme was compared and found to yield a predicted value of 135 kDa. Since the yersiniae enzymes have essentially the same particle size as the E. coli AspA, they likely also exist predominantly as tetramers in solution. This assumption was supported by gel filtration studies, in which a mixture of purified E. coli and yersiniae enzymes co-eluted from a Superdex 200 size-exclusion column. Native gel electrophoresis also showed bands at the same position as the E. coli AspA for each of the yersiniae enzymes, although some smearing was observed for the Y. pestis AspA (data not shown), suggesting partial equilibrium with a lower molecular mass component. These findings argue against the possibility that loss of activity reflects significant changes in subunit association.
AspA from Y. pseudotuberculosis and Y. pestis was also examined by CD spectroscopy over the wavelength range 190–260 nm to assess possible changes in secondary structure that could be responsible for the observed catalytic differences. The two native enzymes exhibited virtually identical spectra (Fig. 3), indicating similar overall folding and secondary structure. A nearly identical CD spectrum was also measured for the V363L mutant of Y. pseudotuberculosis aspartase. Therefore the mutations in primary structure found to cause dramatic differences in catalytic activity evidently do not promote significant changes in secondary structure. Samples of Y. pseudotuberculosis and Y. pestis AspA were also examined by mass spectrometry to identify potential covalent protein modifications at specific amino acids that could be capable of causing the observed changes in activity. The molecular mass of the CRIM from Y. pestis as determined by ESI-MS was 52 526 Da compared to a calculated mass of 52 536 Da; the corresponding value estimated for the AspA of Y. pseudotuberculosis was within 2 Da of the calculated molecular mass of 52 474 Da. These results indicate that covalent modifications do not account for the dramatic differences in catalytic activity observed between the two proteins.
|
|
DISCUSSION |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
). While many of these differences are conservative replacements, there are nine positions in which polar or non-polar amino acids are replaced by charged residues, an additional five positions where charged residues have been replaced by uncharged amino acids, and two positions where positively and negatively charged amino acids have been swapped. Despite these extensive changes, the kinetic parameters of the E. coli and Y. pseudotuberculosis aspartases are indistinguishable. As previously defined, the sequences of the L-aspartases from Y. pseudotuberculosis and Y. pestis are virtually identical (differing by only one or two amino acids) yet the Y. pestis enzyme is essentially inactive. This relationship suggests that the identity of the amino acids at these positions, Asp146 and Val363, must play significant roles in maintaining catalytic activity.
Structural comparison of aspartases
Several members within this ammonia-lyase family catalyse a deamination reaction that is related to that of aspartase, and they do so by a mechanism involving a dehydroalanine that is generated through modification of an active site serine (Langer et al., 1994; Schuster & Rétey, 1995). However, no such modifications were observed by mass spectrometry in the yersiniae aspartases that could account for the observed differences in activity. While changes in the identity of the amino acids at these positions were shown to have a dramatic impact on the catalytic activity of aspartase, this effect is not caused by significant changes in the higher-order structure of the Y. pestis protein. CD spectra of the active and inactive forms of aspartase are nearly identical, indicating no substantial changes in secondary structure. DLS and size-exclusion chromatography data are consistent with tetrameric structures for each enzyme form.
Active site structure of L-aspartases
We have examined the location of Asp146 and Val363 within the aspartase structure to gain a better understanding of their potential roles. The location of the active site of aspartase was previously determined by comparing the apo-aspartase structure (Shi et al., 1997) with E. coli fumarase C (Weaver et al., 1995; Weaver & Banaszak, 1996), a well-studied enzyme from the same family that catalyses a similar reaction. There are four active sites in the tetramer of aspartase, with each active site found at the junction of sets of three out of the four subunits. For example, the putative active site residues of one such site in E. coli aspartase includes the proposed substrate-binding groups Lys327 from subunit C and Arg29 from subunit A, along with the catalytic Ser143 from subunit A and an additional loop from subunit D (Fig. 4). Each of these active site amino acids is fully conserved throughout the entire aspartase family. Ser143 was proposed to function as a catalytic acid (Jayasekera et al., 1997), and a conservative substitution of Ser143 by threonine results in a dramatic loss of catalytic activity to <2 % that of native aspartase (Jayasekera & Viola, 1999). However, the amino acid at position 363 is more than 10 Å (1 nm) away from the putative substrate-binding residues. Thus, there is a low possibility for changes at this position to affect substrate binding. This is consistent with the unaltered Michaelis constant for L-aspartate within the tested family of yersiniae enzymes (Table 2). The amino acid at the other varied position, Asp146, is situated adjacent to the putative catalytic amino acid, Ser143, with the aspartate carboxyl oxygen about 2.8 Å (0.28 nm) from the serine hydroxyl group (Fig. 4). This carboxylate group is involved in helping to position this serine for catalysis, along with Asn145. A non-conservative replacement of Asp146 would certainly disrupt the orientation of the serine side chain and diminish catalytic efficiency. However, as noted, a mutation leading to a tyrosine in position 146 is only observed in the Y. pestis KIM strain, while the other low-activity yersiniae isolates retain an aspartate at this position. Replacement of this tyrosine with an aspartic acid was not sufficient to recover enzymic activity, so other changes must also disrupt catalysis in the Y. pestis CRIM.
|
) and is 3.6–4.0 Å (0.36–0.4 nm) away from the closest contacts with Glu334 of subunit C and Gln191 of subunit D. The comparable amino acids in fumarase (Glu331 and His188) form a charge-relay pair that is proposed to activate a water molecule for proton abstraction from the L-malate substrate (Weaver & Banaszak, 1996). However, this putative catalytic histidine of fumarase is a glutamine in the aspartases, a functional group that could not be involved in the proposed charge-relay system. Thus, the roles of these residues are not as well established for aspartases. The side chain of Val363 in the catalytically active E. coli and Y. pseudotuberculosis aspartases is small enough to avoid steric clashes with the side chains of Glu334 and Gln191. However, the enzymes with low catalytic activity each have larger residues at this position. Even the conservative mutation to a leucine with a slightly larger side chain volume in Y. pestis aspartase was found to have a great impact on catalytic activity. These observations suggest that mutations at position 363 indirectly inhibit enzyme activity, perhaps by causing the catalytic residues Glu334 and Gln191 to alter their positions, thus disrupting their contributions to catalysis.
Excretion of L-aspartate
The species-specific deficiency of AspA activity (Dreyfus & Brubaker, 1978) and attendant secretion of L-aspartate by Ca2+-starved Y. pestis is well established (Brubaker, 2005, 2007). Nevertheless, only a casual relationship existed between these phenomena prior to this study, which detected no significant differences in major enzymes that influence the aspartate pool other than the AspA of Y. pseudotuberculosis and corresponding CRIM of Y. pestis. Additional work will be required to determine the reasons why secretion of L-aspartate is limited to Ca2+-starved plague bacilli and why Na+ promotes the associated nutritional requirement for Ca2+ (Brubaker, 2007). Structural studies have begun, with the aim of verifying the proposed alterations in side chain positioning at the active site of aspartase. We are also examining the possibility that the loss of enzymic activity caused by these changes may promote acute disease. This prospect is in accord with the finding that the attenuated Microtis biovar of Y. pestis, known to remain virulent for the Muridiae but not humans (Fan et al., 1995), possesses the same functional aspA as does Y. pseudotuberculosis (Zhou et al., 2004).
Concluding remarks
In summary, these results indicate that the observed replacement of one aliphatic amino acid (leucine) for another (valine) in AspA of Y. pestis is hardly conservative and does indeed contribute to the loss of enzymic activity, resulting in major phenotypic changes that define the plague bacillus. Taken together, these findings strongly indicate that the missense mutation at amino acid position 363 accounts for loss of enzymic activity in Y. pestis AspA. Further study will be necessary to determine if the similar event at position 146 is limited to the KIM strain. In this context, isolates possessing only the missense mutation at position 363 could readily revert or suppress this mutation in one step, whereas two such events would be required to restore AspA activity in strain KIM.
|
ACKNOWLEDGEMENTS |
|---|
Edited by: J. Parkhill
|
REFERENCES |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
Baugh, C. L., Lanham, J. W. & Surgalla, M. (1964). Effects of bicarbonate on growth of Pasteurella pestis. II. Carbon dioxide fixation into oxalacetate by cell-free extracts. J Bacteriol 88, 1394–1398.
Blattner, F. R., Plunkett, G., III, Bloch, C. A., Perna, N. T., Burland, V., Riley, M., Collado-Vides, J., Glasner, J. D., Rode, C. K. & other authors (1997). The complete genome sequence of Escherichia coli K-12. Science 277, 1453–1474.
Brownlow, W. J. & Wessman, G. E. (1960). Nutrition of Pasteurella pestis in chemically defined media at temperatures of 36 to 38 C. J Bacteriol 79, 299–304.
Brubaker, R. R. (1991). Factors promoting acute and chronic diseases caused by yersiniae. Clin Microbiol Rev 4, 309–324.
Brubaker, R. R. (2005). Influence of Na+, dicarboxylic amino acids, and pH in modulating the low-calcium response of Yersinia pestis. Infect Immun 73, 4743–4752.
Brubaker, R. R. (2007). Intermediary metabolism, Na+, the low calcium-response, and acute disease. In The Genus Yersinia: from Genomics to Function, pp. 116–129. Edited by R. D. Perry. New York: Springer.
Brubaker, R. R., Beesley, E. D. & Surgalla, M. J. (1965). Pasteurella pestis: role of pesticin I and iron in experimental plague. Science 149, 422–424.
Burrows, T. W. & Bacon, G. W. (1960). V and W antigens in strains of Pasteurella pseudotuberculosis. Br J Exp Pathol 41, 38–44.[Medline]
Chain, P. S., Carniel, E., Larimer, F. W., Lamerdin, J., Stoutland, P. O., Regala, W. M., Georgescu, A. M., Vergez, L. M., Land, M. L. & other authors (2004). Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis. Proc Natl Acad Sci U S A 101, 13826–13831.
Chain, P. S. G., Hu, P., Malfatti, S. A., Radnedge, L., Larimer, F., Vergez, L. M., Worsham, P., Chu, M. C. & Andersen, G. L. (2006). Complete genome sequence of Yersinia pestis strains Antiqua and Nepal516: evidence of gene reduction in an emerging pathogen. J Bacteriol 188, 4453–4463.
Delwiche, E. A., Fukui, G. M., Andrews, A. W. & Surgalla, M. J. (1959). Environmental conditions affecting the population dynamics and the retention of virulence of Pasteurella pestis: the role of carbon dioxide. J Bacteriol 77, 355–380.
Deng, W., Burland, V., Plunkett, G. I., III, Boutin, A., Mayhew, G. F., Liss, P., Perna, N. T., Rose, D. J., Mau, B. & other authors (2002). Genome sequence of Y. pestis KIM. J Bacteriol 184, 4601–4611.
Devignat, R. (1951). Variétés de l'espèce Pasteurella pestis. Nouvelle hypothèse. Bull World Health Organ 4, 247–263.[Medline]
Dreyfus, L. A. & Brubaker, R. R. (1978). Consequences of aspartase deficiency in Yersinia pestis. J Bacteriol 136, 757–764.
Fan, Z., Luo, Y., Wang, S., Jin, L., Zhou, X., Liu, J., Zhang, Y. & Li, F. (1995). Microtus brandti plague in the Xilin Gol Grassland was inoffensive to humans. Chin J Control Endemic Dis 10, 56–57 (in Chinese).
Ferber, D. M. & Brubaker, R. R. (1981). Plasmids in Yersinia pestis. Infect Immun 31, 839–841.
Finegold, M. J., Petery, R. F., Berendt, R. F. & Adams, H. R. (1968). Studies on the pathogenesis of plague. Blood coagulation and tissue responses of Macaca mulatta following exposure to aerosols of Pasteurella pestis. Am J Pathol 53, 99–114.[Medline]
Fowler, J. M. & Brubaker, R. R. (1994). Physiological basis of the low calcium response in Yersinia pestis. Infect Immun 62, 5234–5241.
Grallert, H., Rutkat, K. & Buchner, J. (1998). GroEL traps dimeric and monomeric unfolding intermediates of citrate synthase. J Biol Chem 273, 33305–33310.
Guest, J. R., Roberts, R. E. & Wilde, R. J. (1984). Cloning of the aspartase gene (aspA) of Escherichia coli. J Gen Microbiol 130, 1271–1278.[Medline]
Hayashi, T., Makino, K., Ohnishi, M., Kurokawa, K., Ishii, K., Yokoyama, K., Han, C. G., Ohtsubo, E., Nakayama, K. & other authors (2001). Complete genome sequence of enterohemorrhagic Escherichia coli O157 : H7 and genomic comparison with a laboratory strain K-12. DNA Res 8, 11–22.[Abstract]
Higuchi, K. & Smith, J. L. (1961). Studies on the nutrition and physiology of Pasteurella pestis: VI. A differential plating medium for the estimation of the mutation rate to avirulence. J Bacteriol 81, 605–608.
Hu, P., Elliott, J., McCready, P., Skowronski, E., Garnes, J., Kobayashi, A., Brubaker, R. R. & Garcia, E. (1998). Structural organization of virulence-associated plasmids of Yersinia pestis. J Bacteriol 180, 5192–5202.
Jayasekera, M. M. & Viola, R. E. (1999). Recovery of catalytic activity from an inactive aggregated mutant of L-aspartase. Biochem Biophys Res Commun 264, 596–600.[CrossRef][Medline]
Jayasekera, M. M. K., Shi, W., Farber, G. K. & Viola, R. E. (1997). Evaluation of functionally important amino acids in L-aspartate ammonia-lyase from Escherichia coli. Biochemistry 36, 9145–9150.[CrossRef][Medline]
Karsten, W. E., Hunsley, J. R. & Viola, R. E. (1985). Purification of aspartase and aspartokinase-homoserine dehydrogenase I from Escherichia coli by dye-ligand chromatography. Anal Biochem 147, 336–341.[CrossRef][Medline]
Kawahara, K., Tsukano, H., Watanabe, H., Lindler, B. & Matsuura, M. (2002). Modification of the structure and activity of lipid A in Yersinia pestis lipopolysaccharide by growth temperature. Infect Immun 70, 4092–4098.
Kukkonen, M., Suomalainen, M., Kyllonen, P., Lahteenmaki, K., Lang, H., Virkola, R., Helander, I., Holst, O. & Korhonen, T. (2004). Lack of O-antigen is essential for plasminogen activation by Yersinia pestis and Salmonella enterica. Mol Microbiol 51, 215–225.[CrossRef][Medline]
Kutyrev, V. V., Popov, Y. A. & Protsenko, O. A. (1986). Pathogenicity plasmids of the plague microbe (Yersinia pestis). Mol Gen Mikrobiol Virusol 6, 3–11.[Medline]
Langer, M., Reck, G., Reed, J. & Rétey, J. (1994). Identification of serine-143 as the most likely precursor of dehydroalanine in the active site of histidine ammonia-lyase. A study of the overexpressed enzyme by site-directed mutagenesis. Biochemistry 33, 6462–6467.[CrossRef][Medline]
Mehigh, R. J. & Brubaker, R. R. (1993). Major stable peptides of Yersinia pestis synthesized during the low-calcium response. Infect Immun 61, 13–22.
Mortlock, R. P. (1962). Gluconate metabolism of Pasteurella pestis. J Bacteriol 84, 53–59.
Mortlock, R. P. & Brubaker, R. R. (1962). Glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase activities of Pasteurella pestis and Pasteurella pseudotuberculosis. J Bacteriol 84, 1122–1123.
Motin, V. L., Nakajima, R., Smirvov, G. B. & Brubaker, R. R. (1994). Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide. Infect Immun 62, 4192–4201.
Motin, V. L., Georgescu, A. M., Fitch, J. P., Gu, P. P., Nelson, D. O., Mabery, S. L., Garnham, J. B., Sokhansanj, B. A., Ott, L. L. & other authors (2004). Temporal global changes in gene expression during temperature transition in Yersinia pestis. J Bacteriol 186, 6298–6305.
Parkhill, J., Wren, B. W., Thomson, N. R., Titball, R. W., Holden, M. T., Prentice, M. B., Sebaihia, M., James, K. D., Churcher, C. & other authors (2001). Genome sequence of Yersinia pestis, the causative agent of plague. Nature 413, 523–527.[CrossRef][Medline]
Perry, R. D. & Fetherston, J. D. (1997). Yersinia pestis – etiologic agent of plague. Clin Microbiol Rev 10, 35–66.[Abstract]
Rosqvist, R., Skurnik, M. & Wolf-Watz, H. (1988). Increased virulence of Yersinia pseudotuberculosis by two independent mutations. Nature 334, 522–525.[CrossRef][Medline]
Schuster, B. & Rétey, J. (1995). The mechanism of action of phenylalanine ammonia-lyase: the role of prosthetic dehydroalanine. Proc Natl Acad Sci U S A 92, 8433–8437.
Shi, W. X., Dunbar, J. L., Jayasekera, M. M., Viola, R. E. & Farber, G. K. (1997). The structure of L-aspartate ammonia-lyase from Escherichia coli. Biochemistry 36, 9136–9144.[CrossRef][Medline]
Sodeinde, O. A., Subrahmanyam, Y. V. B. K., Stark, K., Quan, T., Bao, Y. & Goguen, J. D. (1992). A surface protease and the invasive character of plague. Science 258, 1004–1007.
Srere, P. A. (1969). Citrate synthase. Methods Enzymol 13, 3–11.
Surgalla, M. J. & Beesley, E. D. (1969). Congo red-agar plating medium for detecting pigmentation in Pasteurella pestis. Appl Microbiol 18, 834–837.[Medline]
Surgalla, M. J., Andrews, A. W. & Baugh, C. L. (1964). Effects of bicarbonate on growth of Pasteurella pestis. I. Differential response of virulent and avirulent cells. J Bacteriol 88, 269–272.
Thal, E. & Knapp, W. (1971). A revised antigenic scheme of Yersinia pseudotuberculosis. Symp Ser Immunobiol Stand 15, 219–222.
Une, T. & Brubaker, R. R. (1984). Roles of V antigen in promoting virulence and immunity in yersiniae. J Immunol 133, 2226–2230.[Abstract]
Watanabe, Y., Iwakura, M., Tokushige, M. & Eguchi, G. (1981). Studies on aspartase. VII. Subunit arrangement of Escherichia coli aspartase. Biochim Biophys Acta 661, 261–266.[Medline]
Weaver, T. M. & Banaszak, L. J. (1996). Crystallographic studies of the catalytic and a second site in fumarase C from Escherichia coli. Biochemistry 35, 13955–13965.[CrossRef][Medline]
Weaver, T. M., Levitt, D. G., Donnelly, M. I., Wilkens-Stevens, P. P. & Banaszak, L. J. (1995). The multisubunit active site of fumarase C from Escherichia coli. Nat Struct Biol 2, 654–662.[CrossRef][Medline]
Yellin, T. O. & Wriston, J. C. (1966). Purification and properties of guinea pig serum asparaginase. Biochemistry 5, 1605[CrossRef][Medline]
Zhou, D., Tong, Z., Song, Y., Han, Y., Pei, D., Pang, X., Zhai, J., Li, M., Cui, B. & other authors (2004). Genetics of metabolic variations between Yersinia pestis biovars and the proposal of a new biovar, microtus. J Bacteriol 186, 5147–5152.
Received 2 December 2007;
revised 6 February 2008;
accepted 6 February 2008.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ||
), charged amino acids replaced by neutral residues (
), and reversals of positively and negatively charged groups (
).
-globulin) (lane 6). Positions of size standards (kDa) are shown on the left.
) and the V363L mutant of Y. pseudotuberculosis (